QIAGEN N.V. Interest Expense | QGEN

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense QIAGEN N.V.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-6.65 M	-739 K	-5.71 M	6.74 M	54.5 M	71.3 M	74.2 M	67.3 M	49.7 M	39 M	37.4 M	39.3 M	30.9 M	23.5 M	25.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
74.2 M	-6.65 M	33.7 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Syneos Health SYNH	82.4 M	-	-	$ 4.46 B	USA
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
Renalytix AI plc RNLX	249 K	-	5.66 %	$ 22.7 M	Britain
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Psychemedics Corporation PMD	26 K	-	-1.84 %	$ 15.3 M	USA
Quotient Limited QTNT	11.6 M	-	-11.32 %	$ 1.1 M	Schweiz
T2 Biosystems TTOO	-495 K	-	-39.35 %	$ 313 K	USA
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
Bioventus BVS	-1.45 M	$ 13.0	1.39 %	$ 866 M	USA
DarioHealth Corp. DRIO	-1.93 M	$ 6.75	2.31 %	$ 26.9 M	Israel
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Accelerate Diagnostics AXDX	-595 K	-	-61.36 %	$ 2.46 M	USA
Anixa Biosciences ANIX	500 K	$ 2.69	1.45 %	$ 87.3 K	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Biodesix BDSX	7.72 M	$ 27.7	1.09 %	$ 209 M	USA
BioNano Genomics BNGO	5.9 M	$ 1.56	17.29 %	$ 8.49 M	USA
Burning Rock Biotech Limited BNR	-30 K	$ 11.68	0.69 %	$ 123 M	China
CareDx, Inc CDNA	524 K	$ 52.64	0.52 %	$ 2.81 B	USA
Celcuity CELC	5.33 M	$ 82.7	0.1 %	$ 3.87 B	USA
Co-Diagnostics CODX	106 K	$ 1.14	2.7 %	$ 1.52 M	USA
Charles River Laboratories International CRL	-22.6 M	$ 272.88	0.59 %	$ 13.5 B	USA
Castle Biosciences CSTL	144 K	$ 35.5	6.16 %	$ 1.03 B	USA
Quest Diagnostics Incorporated DGX	26 M	$ 247.08	3.9 %	$ 27.4 B	USA
Meridian Bioscience VIVO	1.19 M	-	-	$ 1.49 B	USA
Biomerica BMRA	367	$ 2.3	0.42 %	$ 6.7 M	USA
Fulgent Genetics FLGT	153 K	$ 21.28	3.05 %	$ 655 M	USA
Guardant Health GH	-10.5 M	$ 175.65	4.65 %	$ 22 B	USA
ICON Public Limited Company ICLR	337 M	$ 172.45	2.08 %	$ 13.5 B	Irlanda
IDEXX Laboratories IDXX	41.6 M	$ 510.73	0.23 %	$ 41.1 B	USA
Danaher Corporation DHR	-222 M	$ 209.36	3.01 %	$ 149 B	USA
Illumina ILMN	340 M	$ 222.29	6.76 %	$ 34.5 B	USA
IQVIA Holdings IQV	729 M	$ 269.67	1.51 %	$ 46.4 B	USA
Laboratory Corporation of America Holdings LH	224 M	$ 323.97	2.75 %	$ 27 B	USA
Lantheus Holdings LNTH	31.3 M	$ 100.73	0.41 %	$ 6.8 B	USA
DexCom DXCM	177 M	$ 86.45	2.09 %	$ 33.7 B	USA
Medpace Holdings MEDP	-5.34 M	$ 620.48	4.21 %	$ 17.9 B	USA
Mettler-Toledo International MTD	68.5 M	$ 1 330.4	3.47 %	$ 27.4 B	Schweiz
Myriad Genetics MYGN	800 K	$ 3.88	2.37 %	$ 359 M	USA
ENDRA Life Sciences NDRA	-691 K	$ 5.66	1.13 %	$ 4.45 M	USA
NeoGenomics NEO	296 K	$ 18.89	2.61 %	$ 2.42 B	USA
Neogen Corporation NEOG	24.1 M	$ 12.25	2.51 %	$ 2.66 B	USA
National Research Corporation NRC	-95 K	$ 21.96	5.63 %	$ 492 M	USA
Natera NTRA	4.07 M	$ 350.78	2.63 %	$ 48 B	USA
OPKO Health OPK	207 M	$ 1.57	0.64 %	$ 1.18 B	USA
Pacific Biosciences of California PACB	14.8 M	$ 1.34	0.37 %	$ 402 M	USA
Koninklijke Philips N.V. PHG	288 M	$ 24.9	1.99 %	$ 23.6 B	Niderland
Personalis PSNL	205 K	$ 16.1	0.31 %	$ 1.44 B	USA